Orion’s pharmaceutical innovations are created within its R&D organisation. The organisation employs top professionals in the field of drug molecule development and optimisation.
Orion Research Foundation sr is distributing EUR 990,000 in research grants based on applications for 2018. Orion Reaserch Foundation awards grants of max EUR 25,000 for 21 researchers for postdoctoral research and max EUR 5,000 for 139 young researchers for doctoral dissertation work.
Here we provide for download scientific publications released at congresses in which Orion is participating or in other contexts.
Pipeline presents Orion's key clinical pharmaceutical development projects.
What does it take to develop a new medicine? To start with, you need a dedicated team of top scientists and other professionals. The journey might take up to fifteen years. Take a look!
Like in all other operations, our aim is to work in accordance with the requirements, standards and ethical codes of our industry in our pharmaceutical research and development activities too. Our R&D Policy highlights how we make sure that our practices are on an ethically sustainable basis.
Partnerships and networking are important for Orion throughout the entire value chain of operations. We collaborate with other companies in research and development, manufacturing and marketing of products internationally.
The Orion R&D aims to be the best in the world. Reijo Salonen, Senior Vice President of R&D, tells why and how.